High-Risk Alcohol Use Is Associated With Significantly Greater Risk of Incident Hepatocellular Carcinoma in a National Cohort of US Veterans With Metabolic Dysfunction Associated Fatty Liver Disease

被引：0
|
作者：
Wong, Robert J. [1 ,2 ]
Yang, Zeyuan [2 ]
Cheung, Ramsey [1 ]
Singal, Ashwani K. [3 ]
Do, Albert [4 ]
Ahmed, Aijaz [5 ]
Yeoh, Aaron [5 ]
机构：
[1] Stanford Vet Affairs Palo Alto, Palo Alto, CA USA
[2] Vet Affairs Palo Alto, Palo Alto, CA USA
[3] Univ South Dakota, Sioux Falls, SD USA
[4] Yale Sch Med, New Haven, CT USA
[5] Stanford, Stanford, CA USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2023年 / 118卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
S1360
引用
收藏
页码：S1043 / S1043
页数：1
相关论文
共 50 条
  • [21] DIABETIC METABOLIC DYSFUNCTION-ASSOCIATED FATTY LIVER DISEASE IS ASSOCIATED WITH INCREASED RISK OF HEPATOCELLULAR CARCINOMA AND MORTALITY IN CHRONIC VIRAL HEPATITIS PATIENTS
    Kim, Mi Na
    Han, Kyungdo
    Yoo, Juhwan
    Hwang, Seong-Gyu
    Ahn, Sang Hoon
    HEPATOLOGY, 2022, 76 : S244 - S245
  • [22] Metabolic dysfunction-associated steatotic liver disease, metabolic alcohol-related liver disease, and incident dementia: a nationwide cohort studyMASLD, MetALD, and dementia risk
    Woo-Young Shin
    Eun Seok Kang
    Yun Hwan Oh
    Meng Sha
    Qiang Xia
    Seogsong Jeong
    Yoosun Cho
    BMC Gastroenterology, 25 (1)
  • [23] Metabolic dysfunction-associated fatty liver disease increases the risk of complications after radical resection in patients with hepatocellular carcinoma
    Xiong, Ke-Gong
    Ke, Kun-Yu
    Kong, Jin-Feng
    Lin, Tai-Shun
    Lin, Qing-Biao
    Lin, Su
    Zhu, Yue-Yong
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2024, 22 (01)
  • [24] Metabolic dysfunction-associated fatty liver disease subgroups and risk of hepatocellular carcinoma and mortality in patients with chronic viral hepatitis
    Kim, Mi Na
    Han, Kyungdo
    Yoo, Juhwan
    Hwang, Seong Gyu
    Ahn, Sang Hoon
    JOURNAL OF HEPATOLOGY, 2022, 77 : S100 - S100
  • [25] Hepatocellular carcinoma in patients with metabolic dysfunction-associated fatty liver disease: Can we stratify at-risk populations?
    Fassio, Eduardo
    Barreyro, Fernando J.
    Perez, M. Soledad
    Davila, Diana
    Landeira, Graciela
    Gualano, Gisela
    Ruffillo, Gabriela
    WORLD JOURNAL OF HEPATOLOGY, 2022, 14 (02) : 354 - 371
  • [26] Hepatocellular carcinoma in patients with metabolic dysfunction-associated fatty liver disease: Can we stratify at-risk populations?
    Eduardo Fassio
    Fernando J Barreyro
    M Soledad Pérez
    Diana Dávila
    Graciela Landeira
    Gisela Gualano
    Gabriela Ruffillo
    World Journal of Hepatology, 2022, 14 (02) : 354 - 371
  • [27] Metabolic dysfunction-associated fatty liver disease and hepatocellular carcinoma: present and future
    Gao, Feng
    Chen, Gang
    Byrne, Christopher D.
    Targher, Giovanni
    Cheung, Tan To
    Zheng, Ming-Hua
    HEPATOBILIARY SURGERY AND NUTRITION, 2023, 12 (06) : 945 - 948
  • [28] Correlation analysis of metabolic characteristics and the risk of metabolic-associated fatty liver disease - related hepatocellular carcinoma
    Xie, Xuancheng
    Zheng, Mengyao
    Guo, Weibo
    Zhou, Ying
    Xiang, Zhao
    Li, Yuting
    Yang, Jinhui
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [29] Correlation analysis of metabolic characteristics and the risk of metabolic-associated fatty liver disease - related hepatocellular carcinoma
    Xuancheng Xie
    Mengyao Zheng
    Weibo Guo
    Ying Zhou
    Zhao Xiang
    Yuting Li
    Jinhui Yang
    Scientific Reports, 12
  • [30] Cardiovascular Disease Risk and Statin Use Among Adults with Metabolic Dysfunction Associated Fatty Liver Disease
    Yeoh, Aaron
    Cheung, Ramsey
    Ahmed, Aijaz
    Chitnis, Amit S.
    Do, Albert
    Wong, Robert J.
    AMERICAN JOURNAL OF MEDICINE, 2023, 136 (07): : 669 - 676.e1
12345